Emergent BioSolutions, Inc. (EBS)
8.23
+0.20
(+2.49%)
USD |
NYSE |
Apr 28, 16:00
8.23
0.00 (0.00%)
After-Hours: 19:46
Emergent BioSolutions EPS Diluted (Quarterly) : -1.042 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SIGA Technologies, Inc. | -0.0758 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -54.60M |
| Revenue (Quarterly) | 148.70M |
| Total Expenses (Quarterly) | 203.30M |
| Enterprise Value | 790.32M |
| Gross Profit Margin (Quarterly) | 31.34% |
| Profit Margin (Quarterly) | -36.72% |
| Earnings Yield | 10.08% |
| Operating Earnings Yield | 24.10% |
| Normalized Earnings Yield | 13.75 |